Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | RAB9A | P51151 | 2/20 | 0.64 |
| ▸ | NPC1 | O15118 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | APEX1 | P27695 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | GSK3B | P49841 | 1/20 | 0.56 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.56 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.56 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.56 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL153386 | 0.87 | ALDH1A1 (0.76) | KMT2AALDH1A1NPC1LMNAALOX15 | |
| SCHEMBL269939 | 0.87 | USP5 (0.66) | MEN1KMT2AALDH1A1RAB9ANPC1 | |
| SCHEMBL17112793 | 0.85 | NPC1 (0.63) | MEN1KMT2AALDH1A1RAB9ANPC1 | |
| Avobenzone SCHEMBL6595907 | 0.85 | ALDH1A1 (0.72) | MEN1KMT2AALDH1A1RAB9ANPC1 | |
| SCHEMBL5306428 | 0.85 | ALDH1A1 (0.52) | MEN1KMT2AALDH1A1RAB9ANPC1 | |
| SCHEMBL269577 | 0.84 | NPC1 (0.52) | MEN1KMT2AALDH1A1RAB9ANPC1 | |
| SCHEMBL10070207 | 0.84 | RAB9A (0.68) | MEN1KMT2AALDH1A1RAB9ANPC1 | |
| SCHEMBL10070206 | 0.84 | RAB9A (0.68) | MEN1KMT2AALDH1A1RAB9ANPC1 | |
| SCHEMBL7638085 | 0.83 | NPC1 (0.58) | MEN1KMT2AALDH1A1RAB9ANPC1 | |
| SCHEMBL28824890 | 0.82 | KCNH2 (0.70) | MEN1KMT2AALDH1A1RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1793798-B1 | PHOTO-STABLE COSMETIC OR DERMATOLOGICAL COMPOSITIONS | BASF SE (DE) | 2016-04-20 | — | — | EP | disclosed |
| US-20120121524-A1 | PHOTO-STABLE COSMETIC OR DERMATOLOGICAL COMPOSITIONS | MUELLER STEFAN (DE) | 2012-05-17 | — | — | US | disclosed |
| US-20120121524-A1 | PHOTO-STABLE COSMETIC OR DERMATOLOGICAL COMPOSITIONS | MUELLER STEFAN (DE) | 2012-05-17 | — | — | US | disclosed |
| US-8119107-B2 | Photo-stable cosmetic or dermatological compositions | BASF SE (DE) | 2012-02-21 | — | — | US | disclosed |
| US-8119107-B2 | Photo-stable cosmetic or dermatological compositions | BASF SE (DE) | 2012-02-21 | — | — | US | disclosed |
| US-20100143272-A1 | Photo-stable cosmetic or dermatological compositions | CIBA SPECIALTY CHEMICALS CORPORATION | 2010-06-10 | — | — | US | disclosed |
| US-20100143272-A1 | Photo-stable cosmetic or dermatological compositions | CIBA SPECIALTY CHEMICALS CORPORATION | 2010-06-10 | — | — | US | disclosed |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2010-02-25 | — | — | US | disclosed |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2010-02-25 | — | — | US | disclosed |
| WO-2008083974-A1 | ACTIVE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | disclosed |
| WO-2008067928-A1 | UV ABSORBING COMPOSITIONS CONTAINING A PYRROLYLTRIAZINE | ISDIN S.A. (ES) | 2008-06-12 | — | — | WO | disclosed |
| US-6448304-B1 | POLYURETHANE, POLYTHIOURETHANE OR DIETHYLENE GLYCOL BISALLYLCARBONATE POLYMER; DIPPING IN SOLUTION CONTAINING A DIBENZOYLMETHANE OR A BENZOTRIZOLE COMPOUND; PLASTIC LENS FOR SPECTACLES WHICH ABSORBS ULTRAVIOLET RAYS; LOW YELLOWNESS | HOYA CORPORATION (JP) | 2002-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120121524-A1 | PHOTO-STABLE COSMETIC OR DERMATOLOGICAL COMPOSITIONS | NISCH, CUTA, MITF | MEN1 2580/4885KMT2A 2049/4885ALDH1A1 241/4885 |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | UGT2B17, TACR2, UGT1A1 | MEN1 2776/4885KMT2A 3114/4885ALDH1A1 28/4885 |
| US-20100143272-A1 | Photo-stable cosmetic or dermatological compositions | DBF4, CUTA, ARSA | MEN1 975/4885KMT2A 742/4885ALDH1A1 325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.